Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy.
Semba
C P
CP
Department of Interventional Radiology, Stanford University Medical Center, CA 94305, USA. csemba@stanford.edu
Bakal
C W
CW
Calis
K A
KA
Grubbs
G E
GE
Hunter
D W
DW
Matalon
T A
TA
Murphy
T P
TP
Stump
D C
DC
Thomas
S
S
Warner
D L
DL
D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D002406:Catheterization, Peripheral; D006083:Graft Occlusion, Vascular / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D020246:Venous Thrombosis / Q000188:drug therapy
D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator